Aalok Patel

Aalok Patel

Auto-generated profile, based on publicly available information

Aalok Patel

Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St Louis, Mo

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2015 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
CRCliff G. Robinson
Cliff G. Robinson
APAalok P. Patel
Aalok P. Patel
JBJeffrey D. Bradley
Jeffrey D. Bradley
TDTodd DeWees
Todd DeWees
SWSaiama N. Waqar
Saiama N. Waqar
VPVarun Puri
Varun Puri
Purpose: To investigate the impact of modern postoperative radiotherapy (PORT) on overall survival (OS) for patients with N2 non–small-cell lung cancer (NSCLC) treated nationally with surgery and adjuvant chemotherapy. Patients and Methods: Patients with pathologic N2 NSCLC who underwent complete resection and adjuvant chemotherapy from 2006 to 2010 were identified from the National Cancer Data Base and stratified by use of PORT (≥ 45 Gy). A total of 4,483 patients were identified (PORT, n = 1,850; no PORT, n = 2,633). The impact of patient and treatment variables on OS was explored using Cox regression. Results: Median follow-up time was 22 months. On univariable analysis, improved OS correlated with younger age, treatment at an academic facility, female sex, urban population, higher income, lower Charlson comorbidity score, smaller tumor size, multiagent chemotherapy, resection with at least a lobectomy, and PORT. On multivariable analysis, improved OS remained independently predicted by younger age, female sex, urban population, lower Charlson score, smaller tumor size, multiagent chemotherapy, resection with at least a lobectomy, and PORT (hazard ratio, 0.886; 95% CI, 0.798 to 0.988). Use of PORT was associated with an increase in median and 5-year OS compared with no PORT (median OS, 45.2 v 40.7 months, respectively; 5-year OS, 39.3% [95% CI, 35.4% to 43.5%] v 34.8% [95% CI, 31.6% to 38.3%], respectively; P = .014). Conclusion: For patients with N2 NSCLC after complete resection and adjuvant chemotherapy, modern PORT seems to confer an additional OS advantage beyond that achieved with adjuvant chemotherapy alone.

1 June 2015 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PSPamela Samson
Pamela Samson
APAalok Patel
Aalok Patel
TGTasha Garrett
Tasha Garrett
TCTraves Crabtree
Traves Crabtree
DKDaniel Kreisel
Daniel Kreisel
VPVarun Puri
Varun Puri

1 April 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
IKIvana Knezevic
Ivana Knezevic
APAalok Patel
Aalok Patel
NSNagalingam R. Sundaresan
Nagalingam R. Sundaresan
MGMahesh P. Gupta
Mahesh P. Gupta
RSR. John Solaro
R. John Solaro
MGMadhu Gupta
Madhu Gupta
Postnatal cardiac remodeling is characterized by a marked decrease in the insulin-like growth factor 1 (IGF1) and IGF1 receptor (IGF1R) expression. The underlying mechanism remains unexplored. This study examined the role of microRNAs in postnatal cardiac remodeling. By expression profiling, we observed a 10-fold increase in miR-378 expression in 1-week-old neonatal mouse hearts compared with 16-day-old fetal hearts. There was also a 4-6-fold induction in expression of miR-378 in older (10 months) compared with younger (1 month) hearts. Interestingly, tissue distribution analysis identified miR-378 to be highly abundant in heart and skeletal muscles. In the heart, specific expression was observed in cardiac myocytes, which was inducible by a variety of stressors. Overexpression of miR-378 enhanced apoptosis of cardiomyocytes by direct targeting of IGF1R and reduced signaling in Akt cascade. The inhibition of miR-378 by its anti-miR protected cardiomyocytes against H(2)O(2) and hypoxia reoxygenation-induced cell death by promoting IGF1R expression and downstream Akt signaling cascade. Additionally, our data show that miR-378 expression is inhibited by IGF1 in cardiomyocytes. In tissues such as fibroblasts and fetal hearts, where IGF1 levels are high, we found either absent or significantly low miR-378 levels, suggesting an inverse relationship between these two factors. Our study identifies miR-378 as a new cardioabundant microRNA that targets IGF1R. We also demonstrate the existence of a negative feedback loop between miR-378, IGF1R, and IGF1 that is associated with postnatal cardiac remodeling and with the regulation of cardiomyocyte survival during stress.

1 January 2015 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
VPVarun Puri
Varun Puri
APAalok Patel
Aalok Patel
KMKaustav Majumder
Kaustav Majumder
JBJennifer M. Bell
Jennifer M. Bell
TCTraves D. Crabtree
Traves D. Crabtree
BMBryan F. Meyers
Bryan F. Meyers

1 December 2015 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MBMatthew J. Bott
Matthew J. Bott
APAalok P. Patel
Aalok P. Patel
TCTraves D. Crabtree
Traves D. Crabtree
GCGraham A. Colditz
Graham A. Colditz
DKDaniel Kreisel
Daniel Kreisel
VPVarun Puri
Varun Puri

1 October 2016 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
DMDaniel Morgensztern
Daniel Morgensztern
LDLingling Du
Lingling Du
SWSaiama N. Waqar
Saiama N. Waqar
APAalok Patel
Aalok Patel
PSPamela Samson
Pamela Samson
VPVarun Puri
Varun Puri